UC San Diego
San Diego, California 92123
9 studies enrolling now · 33 studies all time
What they study most
Active Tuberculosis, Acute Myelogenous Leukemia, Advanced Cancer, Anxiety Disorders, B-cell Lymphoma, Bone Tumor, Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm, Burnout, Burnout, Healthcare Workers, Cardiac Disease
Studies at this site
- Psilocybin-Assisted Therapy for Physician Well-Being and Burnout — Recruiting now
- U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures — Recruiting now
- Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. — Recruiting now
- Trial of Ixazomib for Kaposi Sarcoma — Recruiting now
- Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy — Recruiting now
- Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33) — Recruiting now
- A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study — Recruiting now
- IO Vancomycin Administration in TKA — Starting soon
- A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 — Completed
- Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy — Completed
- Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial — Running, not enrolling
- Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL) — Completed
- Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis — Running, not enrolling
- Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol — Completed
- AI Ready and Exploratory Atlas for Diabetes Insights — Enrolling by invitation
- FT516 in Subjects With Advanced Hematologic Malignancies — Stopped early
- Noninvasive Biomarkers of Metabolic Liver Disease 1.1 — Completed
- A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) — Completed
- Connected Catheter - Safety and Effectiveness Study — Stopped early
- Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy — Stopped early
- Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT — Completed
- Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study — Completed
- Neurotherapeutics as an Adjunctive Approach to Enhance Exposure Outcomes in Anxiety — Completed
- Performance Evaluation of the VIDAS TB-IGRA Assay. — Completed
- DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY — Completed
- HW006 LATERAL Thoracotomy — Completed
- Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry — Completed
- Cerebral MRI During Sleep — Completed
- Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies — Completed
- Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant — Completed
- Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD) — Completed
- Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
- Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis — Stopped early